Insulin production by the pancreatic B-cell involves a number of closely integrated steps. The only way to understand insulin production as a whole, and thus identify the potential defects associated with, or responsible for, diabetes, is to gain a better understanding of the molecular mechanism of these individual steps. This is the goal of the present study. For this it will be necessary to study B-cell subcellular fractions (Golgi subfractions, granule subpopulations, and lysosomes). Since subcellular fractionation demands larger amounts of tissue than are readily available using isolated islets, rat insulinoma cells will be used. The insulinoma cells will first be characterized in terms of proinsulin biosynthesis and conversion, and insulin release, to validate them as a model for B-cell function. In order to modify the density or other properties of the organelles of interest before subfractionation, thereby improving the resolution of the subfractionation procedure, the transport of products (including proinsulin) across the Golgi complex will be blocked with monensin or Tris. Proinsulin conversion to insulin will be blocked by incorporation of arginine and lysine analogs; this results in an associated block in the maturation of coated to mature uncoated granules (the clathrin-coated granule being the earliest immature form). The biochemical/ultrastructural transformations selected for detailed study and the issues raised are: 1) Proinsulin processing by the Golgi comlex: proinsulin must in some way be recognized by the Golgi complex and thereby concentrated in select Golgi regions for channeling towards, and ultimate packaging into, secretory granules. The recognition process could be receptor mediated. Putative proinsulin receptors on Golgi membranes will be studied. 2) Proinsulin conversion to isulin: the precise site of initiation of conversion in the Golgi complex will be localized, and the mechanism responsible for bringing proinsulin and the conversion enzyme into contact studied. 3) Granule heterogeneity: the functional significance of coated and uncoated granules will be studied, with particular reference to the mechanism responsible for the preferential release of newly synthesized insulin. 4) Degradation of insulin stores: the mechanism and regulation of this pathway will be studied. Crinophagy is the favored path but has not been confirmed biochemically. The impact of the insulin crystal on sensitivity of insulin to degradation within lysosomes will be evaluated.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK035292-02
Application #
3233571
Study Section
Metabolism Study Section (MET)
Project Start
1985-04-01
Project End
1989-03-31
Budget Start
1986-04-01
Budget End
1987-03-31
Support Year
2
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Joslin Diabetes Center
Department
Type
DUNS #
071723084
City
Boston
State
MA
Country
United States
Zip Code
02215
Dotta, F; Previti, M; Neerman-Arbez, M et al. (1998) The GM2-1 ganglioside islet autoantigen in insulin-dependent diabetes mellitus is expressed in secretory granules and is not beta-cell specific. Endocrinology 139:316-9
Sadoul, K; Lang, J; Montecucco, C et al. (1995) SNAP-25 is expressed in islets of Langerhans and is involved in insulin release. J Cell Biol 128:1019-28
Vollenweider, F; Kaufmann, J; Irminger, J C et al. (1995) Processing of proinsulin by furin, PC2, and PC3 in (co) transfected COS (monkey kidney) cells. Diabetes 44:1075-80
Halban, P A; Irminger, J C (1994) Sorting and processing of secretory proteins. Biochem J 299 ( Pt 1):1-18
Neerman-Arbez, M; Cirulli, V; Halban, P A (1994) Levels of the conversion endoproteases PC1 (PC3) and PC2 distinguish between insulin-producing pancreatic islet beta cells and non-beta cells. Biochem J 300 ( Pt 1):57-61
Orci, L; Halban, P; Perrelet, A et al. (1994) pH-independent and -dependent cleavage of proinsulin in the same secretory vesicle. J Cell Biol 126:1149-56
Halban, P A (1994) Proinsulin processing in the regulated and the constitutive secretory pathway. Diabetologia 37 Suppl 2:S65-72
Ferber, S; Schnedl, W J; BeltrandelRio, H et al. (1994) Molecular strategies for the treatment of diabetes. Transplant Proc 26:363-5
Irminger, J C; Vollenweider, F M; Neerman-Arbez, M et al. (1994) Human proinsulin conversion in the regulated and the constitutive pathways of transfected AtT20 cells. J Biol Chem 269:1756-62
Vollenweider, F; Irminger, J C; Halban, P A (1993) Substrate specificity of proinsulin conversion in the constitutive pathway of transfected FAO (hepatoma) cells. Diabetologia 36:1322-5

Showing the most recent 10 out of 34 publications